These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6818899)

  • 1. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
    Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
    Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
    Gombert ME; Berkowitz LB; Cummings MC
    Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
    McNamara BT; Meyer RD; Pasiecznik KA
    Antimicrob Agents Chemother; 1982 May; 21(5):753-7. PubMed ID: 6213196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
    Gombert ME; Aulicino TM
    Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
    Bustamante CI; Drusano GL; Wharton RC; Wade JC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):632-4. PubMed ID: 3111357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 13. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-formimidoyl thienamycin (MK0787): in vitro study.
    Shadomy S; May RS
    Antimicrob Agents Chemother; 1981 Jan; 19(1):201-4. PubMed ID: 6941741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
    Alford RH
    J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
    Schröter G; Schrettenbrunner A
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.